---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-007176"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2023-03-10T23:59:59+00:00"
generated_at: "2026-06-18T05:27:28.466161+00:00"
event_type: "dividend"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Lipocine Amends Bylaws and Declares Series B Preferred Stock Dividend for Reverse Stock Split Vote

## Summary
- Bylaw Amendment adopted March 7, 2023, reducing stockholder quorum from a majority to one-third of outstanding shares.
- Board declared dividend of 1/1000th share of Series B Preferred Stock per common share, record date March 24, 2023.
- Each Series B Preferred share carries 1,000,000 votes, voting solely on reverse stock split and adjournment proposals.
- Series B Preferred is non-transferable except with common stock; shares are subject to automatic redemption before or after the reverse stock split vote.
- Press release issued March 10, 2023, announcing the pro rata distribution of Series B Preferred Stock to common stockholders.

## SEC filing metadata
- accession: 0001493152-23-007176
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2023-03-10T23:59:59+00:00
- event_type: dividend
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315223007176/0001493152-23-007176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315223007176/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-007176
- JSON: https://secwatch.observer/filing/0001493152-23-007176.json
- Plain text: https://secwatch.observer/filing/0001493152-23-007176.txt

## Key facts
- Governance Changes
  Lipocine Inc.: Bylaw amendment to reduce the stockholder quorum requirement from a majority to one-third of outstanding shares entitled to vote (effective 2023-03-07).
  - Change: bylaw amendment
  - Effective: 2023-03-07
  source text: On March 7, 2023, the board of directors the (“ Board ”) of Lipocine Inc. (the “ Company ”), adopted and approved an amendment to the Company’s Amended and Restated Bylaws (the “ Bylaws Amendment ”) in order to change the number of stockholders required to constitute a quorum at a meeting of stockholders, from requiring a majority, to requiring one-third, of the outstanding shares of stock entitled to vote, present in person, by remote communication, or represented by proxy.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1535955/000149315223007176/0001493152-23-007176-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.